F𝗮𝘀𝘁𝗲𝗿 𝗿𝗼𝘂𝘁𝗲𝘀 𝘁𝗼 𝗮𝗱𝗼𝗽𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝘄𝗶𝗱𝗲𝗿 𝘂𝗽𝘁𝗮𝗸𝗲 𝗮𝗰𝗿𝗼𝘀𝘀 𝘁𝗵𝗲 𝗡𝗛𝗦 𝗳𝗼𝗿 𝗹𝗶𝗳𝗲 𝗰𝗵𝗮𝗻𝗴𝗶𝗻𝗴 𝗵𝗲𝗮𝗹𝘁𝗵𝘁𝗲𝗰𝗵 𝗮𝗿𝗲 𝘁𝗵𝗲 𝗸𝗲𝘆 𝘁𝗵𝗲𝗺𝗲𝘀 𝗶𝗻 𝗛𝗲𝗮𝗹𝘁𝗵 𝗧𝗲𝗰𝗵 𝗔𝗹𝗹𝗶𝗮𝗻𝗰𝗲’𝘀 (𝗛𝗧𝗔) 𝗻𝗲𝘄 𝗣𝗼𝗹𝗶𝗰𝘆 𝗕𝗹𝘂𝗲𝗽𝗿𝗶𝗻𝘁.
The HTA, chaired by Dame Barbara Hakin, operates with key decision makers and stakeholders across the NHS with an aim of ultimately improving the health of the nation through innovative healthcare technologies.
In the Blueprint’s foreword Dame Barbara Hakin says “𝘕𝘏𝘚𝘌&𝘐 𝘦𝘴𝘵𝘪𝘮𝘢𝘵𝘦 𝘵𝘩𝘢𝘵 𝘪𝘵 𝘵𝘢𝘬𝘦𝘴 17 𝘺𝘦𝘢𝘳𝘴 𝘰𝘯 𝘢𝘷𝘦𝘳𝘢𝘨𝘦 𝘧𝘰𝘳 𝘢 𝘯𝘦𝘸 𝘱𝘳𝘰𝘥𝘶𝘤𝘵 𝘰𝘳 𝘥𝘦𝘷𝘪𝘤𝘦 𝘵𝘰 𝘨𝘰 𝘧𝘳𝘰𝘮 𝘤𝘭𝘪𝘯𝘪𝘤𝘢𝘭 𝘵𝘳𝘪𝘢𝘭 𝘴𝘵𝘢𝘨𝘦 𝘵𝘰 𝘮𝘢𝘪𝘯𝘴𝘵𝘳𝘦𝘢𝘮 𝘢𝘥𝘰𝘱𝘵𝘪𝘰𝘯. 𝘍𝘰𝘳 𝘪𝘯𝘯𝘰𝘷𝘢𝘵𝘪𝘰𝘯 𝘵𝘰 𝘥𝘦𝘷𝘦𝘭𝘰𝘱 𝘢𝘤𝘳𝘰𝘴𝘴 𝘵𝘩𝘦 𝘕𝘏𝘚, 𝘵𝘩𝘪𝘴, 𝘢𝘭𝘰𝘯𝘨𝘴𝘪𝘥𝘦 𝘵𝘩𝘦 𝘭𝘦𝘷𝘦𝘭 𝘰𝘧 𝘪𝘯𝘷𝘦𝘴𝘵𝘮𝘦𝘯𝘵 𝘪𝘯 𝘮𝘦𝘥𝘪𝘤𝘢𝘭 𝘥𝘦𝘷𝘪𝘤𝘦𝘴, 𝘯𝘦𝘦𝘥𝘴 𝘵𝘰 𝘤𝘩𝘢𝘯𝘨𝘦”.
This document outlines the current, everchanging, adoption challenge alongside patient-centric recommendations for next steps and furthering conversations to approve access to innovative technologies across the UK health system.